Suro Senen

Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed

• Genomics and Precision Medicine

Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed

Suro Senen October 7, 2026

Age-related hearing loss, often dismissed as an inevitable consequence of aging, is a condition of profound complexity....

Read More Read more about Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed

Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed

• Genomics and Precision Medicine

Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed

Suro Senen October 7, 2026

Age-related hearing loss, often dismissed as an inevitable consequence of the aging process, is emerging as a...

Read More Read more about Unlocking the Genetic Architecture of Hearing Loss: A Conversation with Dr. Samah Ahmed

The Architecture of Advocacy: How METAvivor is Reshaping Metastatic Breast Cancer Policy

• Patient Advocacy and Support

The Architecture of Advocacy: How METAvivor is Reshaping Metastatic Breast Cancer Policy

Suro Senen October 7, 2026

Introduction: The Critical Need for Stage IV Representation In the complex landscape of oncological research and healthcare...

Read More Read more about The Architecture of Advocacy: How METAvivor is Reshaping Metastatic Breast Cancer Policy

A Breakthrough in Gynecologic Oncology: Pioneering Clitoral Reconstruction Following Vulvar Cancer Surgery

• Clinical Oncology Education

A Breakthrough in Gynecologic Oncology: Pioneering Clitoral Reconstruction Following Vulvar Cancer Surgery

Suro Senen October 7, 2026

For decades, the standard of care for women diagnosed with vulvar cancer involving the clitoris has been...

Read More Read more about A Breakthrough in Gynecologic Oncology: Pioneering Clitoral Reconstruction Following Vulvar Cancer Surgery

ViiV Healthcare’s Cabenuva Demonstrates Superior Viral Suppression in Phase IIIb CROWN Study, Offering New Hope for Treatment-Experienced Individuals

• Medical Research and Clinical Trials

ViiV Healthcare’s Cabenuva Demonstrates Superior Viral Suppression in Phase IIIb CROWN Study, Offering New Hope for Treatment-Experienced Individuals

Suro Senen October 7, 2026

London, UK – October 26, 2023 – ViiV Healthcare, a global specialist HIV company majority-owned by GSK,...

Read More Read more about ViiV Healthcare’s Cabenuva Demonstrates Superior Viral Suppression in Phase IIIb CROWN Study, Offering New Hope for Treatment-Experienced Individuals

The Digital Renaissance of Pathology: Mining Archives to Redefine Preclinical Research

• Treatment Innovations

The Digital Renaissance of Pathology: Mining Archives to Redefine Preclinical Research

Suro Senen October 6, 2026

In the landscape of modern drug discovery, the traditional animal study has long functioned as a linear,...

Read More Read more about The Digital Renaissance of Pathology: Mining Archives to Redefine Preclinical Research

Breaking Barriers in Sight: Science Corporation’s PRIMA Implant Shows Lasting Efficacy for Geographic Atrophy Patients

• Treatment Innovations

Breaking Barriers in Sight: Science Corporation’s PRIMA Implant Shows Lasting Efficacy for Geographic Atrophy Patients

Suro Senen October 6, 2026

In the rapidly evolving landscape of neural engineering and ophthalmic restoration, Science Corporation has reached a significant...

Read More Read more about Breaking Barriers in Sight: Science Corporation’s PRIMA Implant Shows Lasting Efficacy for Geographic Atrophy Patients

GE HealthCare Bolsters Radiopharmaceutical Dominance with Strategic Acquisition of Sofie Biosciences

• Chemotherapy and Targeted Therapy

GE HealthCare Bolsters Radiopharmaceutical Dominance with Strategic Acquisition of Sofie Biosciences

Suro Senen October 6, 2026

In a move set to reshape the landscape of molecular imaging and personalized medicine, GE HealthCare has...

Read More Read more about GE HealthCare Bolsters Radiopharmaceutical Dominance with Strategic Acquisition of Sofie Biosciences

The Power of the Plate: How Anti-Inflammatory Nutrition is Reshaping Breast Cancer Recovery

• Survivorship and Post-Treatment

The Power of the Plate: How Anti-Inflammatory Nutrition is Reshaping Breast Cancer Recovery

Suro Senen October 6, 2026

In the landscape of modern oncology, the conversation has shifted. It is no longer enough to simply...

Read More Read more about The Power of the Plate: How Anti-Inflammatory Nutrition is Reshaping Breast Cancer Recovery

Turning the Tide: Mount Sinai Scientists Unveil "Trojan Horse" Immunotherapy for Metastatic Cancer

• Medical Research and Clinical Trials

Turning the Tide: Mount Sinai Scientists Unveil "Trojan Horse" Immunotherapy for Metastatic Cancer

Suro Senen October 6, 2026

NEW YORK, NY – January 22, 2024 – In a significant departure from conventional cancer treatment strategies,...

Read More Read more about Turning the Tide: Mount Sinai Scientists Unveil "Trojan Horse" Immunotherapy for Metastatic Cancer